What Has Been The Evolution of the Aortic Endograft Market in Recent Years?
The aortic endograft market has seen considerable growth due to a variety of factors.
• In recent times, the aortic endograft market has been exhibiting robust growth. The market is expected to expand from $3.35 billion in 2024 to $3.55 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.0%.
The surge during the historical period can be attributed to factors such as a growth in medical tourism, the increasing demand for managing aortic aneurysm, a rise in the incidence of aortic aneurysm cases, the technical success associated with endograft implantation, and an increase in the number of hospitals.
What Are the Future Growth Projections for the Aortic Endograft Market?
The aortic endograft market is expected to maintain its strong growth trajectory in upcoming years.
• The market for aortic endografts is predicted to grow steadily over the next few years, expanding to a worth of $4.27 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 4.8%.
Growth within this period can be associated with the rising cases of abdominal aortic aneurysm, the increased favorability of minimally invasive endovascular procedures, an aging population, progress in stent-graft materials and configurations, as well as the launch of new stent-graft items. Significant trends for the forecast period include the integration of endovascular abdominal aortic aneurysm (AAA) repair devices, the effectiveness of both unibody and non-unibody aortic stent, as well as product innovation.
What Are The Core Factors Supporting Growth In The Aortic Endograft Market?
The escalating rate of aortic aneurysms is predicted to stimulate the expansion of the aortic endograft market. The medical term for a focused, unusual dilation or protrusion of the aorta, the body's largest artery, is an aortic aneurysm. Aortic endografts, which are less intrusive than traditional open surgery, are used to address aortic aneurysms. A metal or polymer tool covered in fabric is placed through a catheter, bolstering frail aortic walls while reducing the chance of a rupture. For example, the Government Digital Service, a UK public sector info website, announced that around 274,800 males were provided screenings in February 2023. Among them, 79.0% received a final screen and 1,794 aneurysms were discovered from April 2021 to March 2022. Consequently, the increasing occurrence of aortic aneurysms is propelling the aortic aneurysm market's development.
What Are The Major Segments Within The Global Aortic Endograft Market?
The aortic endograft market covered in this report is segmented –
1) By Product: Abdominal Aortic Grafts, Thoracic Aortic Grafts
2) By Material: Metallic Endografts, Polymeric Endografts
3) By Procedure: Open Surgical Repair, Endovascular Aneurysm Repair (EVAR)
4) By End User: Hospitals, Ambulatory Surgical Centers
Subsegments:
1) By Abdominal Aortic Grafts: Fenestrated Aortic Grafts, Branched Aortic Grafts, Conventional Aortic Grafts
2) By Thoracic Aortic Grafts: Stented Thoracic Aortic Grafts, Non-Stented Thoracic Aortic Grafts, Hybrid Thoracic Aortic Grafts
Pre-Book The Aortic Endograft Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Aortic Endograft Market?
In the aortic endograft market, key players are leveraging innovation to secure a competitive advantage. One example is the development of the medical device, the castor-branched aortic stent graft system, designed for minimally invasive repair of aorta and aortic arch, particularly used in cases of Stanford type B aortic dissection (TBAD). Terumo India, a prominent medical technology company and an Indian subsidiary of Terumo Corporation, exemplified this in August 2024, by launching the TREO Stent-Graft System. This novel solution is intended for Endovascular Aneurysm Repair (EVAR) and is unique in its design for treating infrarenal abdominal aortic aneurysms in adults with suitable anatomies; it's also the only EVAR graft that offers both suprarenal and infrarenal active fixation.
Who Are the Key Players In The Aortic Endograft Market?
Major companies operating in the aortic endograft market report are:
• Cardinal Health Inc.
• Abbott Laboratories
• Medtronic Plc
• Becton
• Dickinson and Company
• Koninklijke Philips N.V.
• Boston Scientific Corporation
• Terumo Corporation
• W. L. Gore & Associates Inc.
• Cook Medical Inc.
• Merit Medical Systems Inc.
• Penumbra Inc.
• LifeTech Scientific Corporation
• Altura Medical Inc.
• MicroVention Inc.
• MicroPort Scientific Corporation
• CryoLife Inc.
• Cordis Corporation
• Endologix LLC
• Braile Biomédica Indústria Comércio e Representações Ltda.
• Nano Endoluminal S.A.
• Biomerics LLC
• JOTEC GmbH
• Lombard Medical Inc.
• Aptus Endosystems Inc.
• Lombardi SA
• Cardiatis S.A.
• Endospan Ltd.
• Transcatheter Technologies GmbH
What Is The Most Dominant Region In The Aortic Endograft Market?
North America was the largest region in the aortic endograft market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic endograft market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
